We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Cedar Fair
FUN
$1.61B
| $43.1M | 0.03% |
2,023,594
+501,302
| +33% | +$10.2M |
|
427
PUT
SPDR Gold Trust
GLD
$148B
| $42.4M | 0.03% |
115,100
-735,800
| -86% | -$305M |
|
428
Kinder Morgan
KMI
$71.2B
| $42.4M | 0.03% |
1,325,501
+1,004,442
| +313% | +$32.4M |
|
429
RBC Bearings
RBC
$15.6B
| $42.3M | 0.03% |
65,629
+55,085
| +522% | +$32.8M |
|
430
Halliburton
HAL
$30.7B
| $42.2M | 0.03% |
1,243,046
-3,301,745
| -73% | -$129M |
|
|
CRNX
431
DELISTED
Crinetics Pharmaceuticals
CRNX
| $42.2M | 0.03% |
1,126,639
+442,531
| +65% | +$16.4M |
|
432
Alcon
ALC
$33.4B
| $42.1M | 0.03% |
623,516
+502,334
| +415% | +$35.2M |
|
|
AEVA
433
Aeva Technologies
AEVA
$1.13B
| $41.9M | 0.03% |
+1,460,269
| New | +$28.7M |
|
434
Littelfuse
LFUS
$10.7B
| $41.8M | 0.03% |
91,785
+31,059
| +51% | +$13.4M |
|
435
Xenon Pharmaceuticals
XENE
$5.77B
| $41.6M | 0.03% |
+689,342
| New | +$38.3M |
|
436
Grocery Outlet
GO
$1.16B
| $41.5M | 0.03% |
4,162,427
+618,160
| +17% | +$5.09M |
|
437
Verizon
VZ
$209B
| $41.5M | 0.03% |
980,500
+788,191
| +410% | +$37M |
|
438
Veeco
VECO
$2.79B
| $41.4M | 0.03% |
546,110
+475,531
| +674% | +$27.1M |
|
439
HCA Healthcare
HCA
$87B
| $41.3M | 0.03% |
105,866
+61,807
| +140% | +$26.1M |
|
440
Atmus Filtration Technologies
ATMU
$3.87B
| $41.1M | 0.03% |
806,251
+483,642
| +150% | +$26.3M |
|
441
Jones Lang LaSalle
JLL
$16.2B
| $41M | 0.03% |
132,381
+108,503
| +454% | +$33.7M |
|
442
Toast
TOST
$19.2B
| $40.9M | 0.03% |
1,470,827
-1,428,794
| -49% | -$37.3M |
|
443
Twist Bioscience
TWST
$8.43B
| $40.8M | 0.03% |
+396,912
| New | +$25.8M |
|
|
AMRZ
444
Amrize Ltd
AMRZ
$22.9B
| $40.7M | 0.03% |
766,056
-782,480
| -51% | -$42.4M |
|
445
Cognizant
CTSH
$27B
| $40.6M | 0.03% |
1,047,671
-457,951
| -30% | -$24.1M |
|
446
Dentsply Sirona
XRAY
$2.19B
| $40.3M | 0.03% |
3,800,116
-708,286
| -16% | -$7.73M |
|
447
PUT
Newmont
NEM
$134B
| $40.3M | 0.03% |
431,400
+39,100
| +10% | +$4.26M |
|
448
Middleby
MIDD
$4.91B
| $40.1M | 0.03% |
233,077
+68,052
| +41% | +$10.3M |
|
|
BNY
449
Bank of New York Mellon
BNY
$110B
| $40.1M | 0.03% |
277,161
-1,090,850
| -80% | -$149M |
|
|
GTLS
450
DELISTED
Chart Industries
GTLS
| $40M | 0.03% |
191,262
+57,099
| +43% | +$11.9M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.